Skip to content

Medical-device intelligence

Accriva Diagnostics, Inc.: FDA clearances and recalls

Research Accriva Diagnostics, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

3 clearance records and 7 recall records in the covered releases, across 1 source company names and 6 product codes. Dated history runs from Nov 22, 2019 to Sep 14, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202501
November 202501
December 202500
January 202600
February 202600
March 202600
April 202601
May 202600
June 202600
July 202600
August 202600
September 202601
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

10 matching records
Device / recordCompany in FDA recordSourceSource date
Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103Z-0317-2027 · JPAAccriva Diagnostics, Inc.RecallOct 30, 2026FDA classification date
directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2Z-2460-2026 · GGNAccriva Diagnostics, Inc.RecallJun 16, 2026FDA classification date
Hemochron Activated Clotting Time Low-Range Test Cuvette, REF: ACT-LR, to be used with the Hemochron Signature ELITE Whole Blood Microcoagulation…Z-0880-2026 · JBPAccriva Diagnostics, Inc.RecallDec 3, 2025FDA classification date
VerifyNow PRUTest Platelet Reactivity Test REF 85225 UDI-DI code: 10711234150078 The VerifyNow PRUTest is a whole blood test used in the laborat…Z-0500-2026 · JOZAccriva Diagnostics, Inc.RecallNov 13, 2025FDA classification date
VerifyNow P2Y12 Platelet Reactivity Test, REF: 85064Z-0961-2025 · JOZAccriva Diagnostics, Inc.RecallJan 16, 2025FDA classification date
AVOXimeter 1000E, Product Number: AVOX1000E. The AVOXimeter 1000E is a battery-operated bedside whole blood oximeter.Z-0279-2025 · DQAAccriva Diagnostics, Inc.RecallOct 31, 2024FDA classification date
TenderfootK223352 · FMKAccriva Diagnostics, Inc.510(k)Mar 2, 2023FDA decision date
The VerifyNow P2Y12 Test is designed to measure platelet P2Y12 receptor blockade. Substances known to specifically block the P2Y12 receptor inclu…Z-1121-2022 · JOZAccriva Diagnostics, Inc.RecallMay 20, 2022FDA record creation date
GEM Hemochron 100 System, GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+), GEM Hemochron 100 Low Range Activated Clotting Time Test (A…K202101 · JPAAccriva Diagnostics, Inc.510(k)Dec 29, 2021FDA decision date
Hemochron Signature EliteK193041 · JPAAccriva Diagnostics, Inc.510(k)Nov 22, 2019FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗